InvestorsHub Logo
Followers 8
Posts 443
Boards Moderated 0
Alias Born 03/25/2016

Re: None

Saturday, 03/26/2016 10:18:08 AM

Saturday, March 26, 2016 10:18:08 AM

Post# of 233104
Clinical results exceed all expectations (per anecdotal comments during Conference Call). Assuming this continues, management will have a myriad of pathways to increase Shareholder Value and the SP . IMO, the Slide Presentation at AMS Microbe will go a long way to validate CYDY's science and credibility. If, between now and June, 20th, the upgraded listing takes place, a commensurate SP should be the result.